key: cord-0744656-3kqbvdo6
authors: Fu, Miao; Fang, Liping; Xiang, Xi; Fan, Xijing; Wu, Junqi; Wang, Jinhua
title: Microarray analysis of circRNAs sequencing profile in exosomes derived from bone marrow mesenchymal stem cells in postmenopausal osteoporosis patients
date: 2021-11-19
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23916
sha: 3fdde237c1e24ea30417f063e157bec5d7cc9502
doc_id: 744656
cord_uid: 3kqbvdo6

INTRODUCTION: Bone marrow‐derived mesenchymal stem cells (BMSCs)‐derived exosomes are involved in the modulation of tissue repair and regeneration. CircRNAs play important roles in BMSCs exosomes. The current study sought to explore the role of circRNAs in exosomes derived from BMSCs of postmenopausal osteoporosis (PMOP) patients and the underlying mechanisms. METHODS: RNA was extracted from BMSCs exosomes of PMOP and a control group. RNA microarray and bioinformatics analyses were used to explore the expression profile and functions circRNAs. Differentially expressed circRNAs from 20 PMOP and 20 controls were analyzed using RT‐qPCR. RESULTS: A total of 237 upregulated and 279 downregulated circRNAs were identified in the current study. The top‐10 most upregulated circRNAs in the PMOP group were hsa_circ_0069691, hsa_circ_0005678, hsa_circ_0006464, hsa_circ_0015813, hsa_circ_0000511, hsa_circ_0076527, hsa_circ_0009127, hsa_circ_0047285, hsa_circ_0027741, and hsa_circ_0090949. The top‐10 most downregulated circRNAs were hsa_circ_0048669, hsa_circ_0090247, hsa_circ_0070899, hsa_circ_0087557, hsa_circ_0045963, hsa_circ_0090180, hsa_circ_0058392, hsa_circ_0040751, hsa_circ_0067910, and hsa_circ_0049484. RT‐PCR verified dysregulation of 5 circRNAs including hsa_circ_0009127, hsa_circ_0090759, hsa_circ_0058392, hsa_circ_0090247, and hsa_circ_0049484. Moreover, a circRNA‐microRNA‐mRNA interaction network was developed based on differentially expressed circRNAs. Functional analysis showed that pathways involved in the regulation of autophagy, PI3K‐Akt signaling, FoxO signaling, and MAPK signaling were associated with the differentially expressed circRNAs in PMOP patients. CONCLUSION: The findings of this study show dysregulated circRNAs in BMSCs exosomes of PMOP patients, which may affect the progression of PMOP. These circRNAs can be used as predictive biomarkers and as therapeutic targets for the treatment of PMOP.

Postmenopausal osteoporosis (PMOP) is a systemic metabolic bone disease caused by a decrease in estrogen secretion and imbalance of bone resorption and bone formation in postmenopausal women. 1 Osteoporotic fractures, including hip fractures and vertebral compression fractures (VCFs), are the most severe manifestations of osteoporosis in elderly women, and the treatment may require highrisk surgery. 2 Previous studies report that higher programmed cell death protein 1 (PD-1) and systemic immune-inflammation index (SII) in the peripheral blood of PMOP patients have potential diagnostic application for PMOP. 3, 4 Although sensitive and effective biomarkers have been identified for early identification of PMOP, current treatment strategies do not fully reverse osteoporosis. Bone marrow-derived mesenchymal stem cells (BMSCs) promoted bone regeneration and play important roles in maintaining normal bone metabolism. 5 Osteogenic differentiation defect is a major cause of osteoporosis. Transplanted exogenous MSCs reverse osteoporosis by regulating osteogenic differentiation of host MSCs, 6, 7 although the underlying mechanism is not fully known.

Notably, communication between osteoblasts and osteoclasts takes place through small membrane-enclosed vesicular particles named as exosomes, which can fuse with the surrounding cell membranes within circulatory pathways. 8 Exosomes are membranebound vesicles whose diameter ranges from 40 to 200 nm and are secreted by various cells to mediate cell-cell communication. 9 Exosomes transfer bioactive lipids, nucleic acids, and proteins across cells. 10 Recent studies report that BMSCs-derived exosomes modulate bone metabolism and the bone microenvironment. 11, 12 Efficient bone regeneration is mainly associated with the paracrine delivery of specific substances to receiving cells through exosomes. In vitro and in vivo studies report that BMSCs-derived exosomes protect cartilage from degeneration. 13, 14 Exosomes produced by human-induced pluripotent stem cell-originated MSCs increase bone rejuvenation of critical-sized calvarial defects in ovariectomized rats by promoting osteogenesis and angiogenesis. 15 Furthermore, exosomes derived from BMSCs are more stable under diverse physiological conditions compared with stem cells and lack immunogenicity; thus, they are suitable for therapeutic intervention. 16 Therefore, exosomes derived from BMSCs are a promising treatment strategy for metabolic bone diseases, including PMOP.

Li et al. 17 reported that circular RNAs (circRNAs) are highly expressed in exosomes. CircRNAs can be divided into non-coding circRNAs and coding circRNAs based on ability to be translated. 18 Studies report that circRNAs act as competing endogenous RNAs (ceRNAs) by sponging miRNAs, thus counteracting their inhibitory effects on gene expression. 19, 20 For example, circSERPINE2 plays a protective role in osteoarthritis by interacting with miR-1271 to regulate E26 transformation-specific-related gene (ERG) expression. 21 CircFOXP1 regulates MSC differentiation by interacting with miR-17-3p/miR-127-5p, and in vivo animal experiments show that circ-FOXP1 modulates MSC bone repair. 22 These studies indicate that circRNA modulates growth, regeneration, and function of osteoblasts, chondrocytes, and osteoclasts. However, the expression profile and mechanism of circRNAs in BMSCs exosomes during PMOP have not been explored.

In the current study, the circRNA expression profile in BMSCs exosomes from PMOP patients was explored through microarray analysis and was compared with that of controls to identify differentially expressed circRNA. Sequence annotation and functional analysis were performed to elucidate the putative biological functions of genes targeted by the differential circRNA candidates. The findings showed that differentially expressed circRNAs are implicated in the modulation of PMOP pathogenesis through autophagy, AMPK signaling, and PI3K-Akt signaling. These findings provide important information for guiding further research on diverse genes and cascades, which are implicated in the onset and progression of PMOP.

Ethical approval for the study was obtained from the ethics committee of Jinhua central hospital. All patients in included in the study signed an informed consent form. Table S1 . Samples were collected from patients during diagnosis or recurrence after obtaining written 

Bone marrow-derived mesenchymal stem cells were characterized by the detection of cell surface antigens with flow cytometry. 

Passage 5 BMSCs were seeded on 24-well plates and cultured with osteogenic medium (Cyagen Biosciences) for 14 days. BMSCs were stained with 10% alizarin red dyestuff (Yeasen) for 10 min and rinsed thrice with PBS 1X followed by examination under an optical microscope (Olympus), and images were obtained.

Passage 5 BMSCs were inoculated in 24-well plates and grown in adipogenic differentiation basal medium A (Cyagen Biosciences). The medium was replaced with adipogenic differentiation basal medium B (Cyagen Biosciences) after 3 days, and cells grown for one more day. These steps were repeated up to day 14 (referred as the 3rd cycle). Cells were then fixed with 4% formalin solution and stained with Oil Red O (Yeasen) for 40 min followed by microscopic examination (Olympus). 

Exosomes and cells were lysed using RIPA buffer (Beyotime) centrifuged at 10,000 g for 20 min. BCA assay kit (Beyotime) was used to quantify the proteins. Proteins were separated on a 10% SDS-PAGE and subsequently blotted onto PVDF membranes. 5% skimmed milk was used to block the membranes for 1 h at room temperature (RT).

The membranes were then incubated overnight with rabbit primary antibodies against CD63, β-actin, CD9, and CD81 (Abcam). Membranes were then washed thrice with TBST (Beyotime) and incubated with HRP-labelled goat anti-rabbit secondary antibody (Beyotime) for 1 h. Enhanced chemiluminescence (ECL) fluorescent detection kit (Beyotime) was used to tag samples with a fluorescence probe, and then, images were obtained using a gel imager. Protein band intensity was quantified by normalizing it based on β-actin band intensity.

An exosome RNA isolation kit (Norgen, Canada) was used to isolate total RNA from exosomes, and NanoDrop ND-2000 (Thermo Scientific) was used to quantify RNA. CircRNA microarray analysis (LC Biotech) was performed to identify differentially expressed circRNAs between PMOP (n = 3) and control (n = 3) samples. Strand-specific cDNA libraries were processed as described previously. 23 Processing of raw reads was performed through the removal of adaptor reads along with low-quality tags. Clean reads were used in downstream analyses. Agilent Scanner G5761A (Agilent Technologies) was used to scan the original image post rolling hybridization at 65°C for 17 h.

Raw data were normalized by quantile algorithm.

circRNAs gene symbols were submitted DAVID webserver, and KEGG pathway enrichment analyses were performed to explore the potential function of circRNAs. Genes and involved pathways were imported into Cytoscape 3.7.2 to construct a network to explore the biological functions of the circRNAs.

One milligram of total RNA was used for first-strand cDNA synthesis Table S2 . The experiment was performed in triplicates.

Statistical analyses were performed using SPSS program. Data were expressed as mean ± SD. Student's t test was used to compare differences between the 2 groups. p < 0.05 was considered statistically significant.

Bone marrow-derived mesenchymal stem cells were isolated using the direct adherent method. Primary BMSCs from healthy women and PMOP patients were cultured successfully. Analysis of BMSCs showed the presence of fibroblasts with high cell density, spindleshape, and wall-attached edges ( Figure 1A) . Flow cytometry analysis of specific surface biomarkers (CD44 and CD90) and a hematopoietic biomarker (CD34 and CD45) in BMSCs showed CD44 and CD90 positive rates of 93.9% ± 1.83% and 99.7% ± 2.78%, respectively, and CD34 and CD45 positive rate at 4.3% ± 0.27% and 2.2% ± 0.25%, respectively ( Figure 1B 

Electron microscopy showed that BMSCs-derived exosomes had a 30-100 nm diameter (Figure 2A) . Western blotting analysis of exosome proteins showed the presence of CD9, CD63, and CD81 ( Figure 2B) , implying that the isolated exosomes were similar to standard and could be used for subsequent experiments.

circRNA expression profiles were comparatively explored in the two exosome groups ( Figure 3A) . circRNA was considered to be differentially expressed if its level in the 2 groups differed by at 

To validate RNA-seq results, 8 circRNAs (p = <0.05, fold change ≥2) and initial expression quantity were selected for RT-qPCR validation. were consistent with the microarray findings ( Figure 4) . Moreover, the expression profile of hsa_circ_0009127, hsa_circ_0090759, hsa_circ_0058392, hsa_circ_0090247, and hsa_circ_0049484 were significantly different between the two groups (p < 0.01, Figure 4 ).

MiRanda and Targetscan tools were used to explore the relationship between circRNAs-miRNAs-mRNAs, and intersection of the 2 software was used as interaction relationship among the 3 types of 

The application of BMSCs for bone tissue repair and rejuvenation has received significant attention in recent years. 5, 24, 25 Several studies report that paracrine actions constitute the primary mechanism by which BMSCs exert therapeutic effects. 26, 27 Exosomes are paracrine factors, which mediate intercellular communication and are important effectors of BMSCs. 28, 29 Several studies have explored the differential expression patterns of non-coding RNAs (ncRNAs) in blood mononuclear and lymphocyte cells from PMOP patients, including lncRNAs, mRNAs, circRNAs, and miRNAs. 30, 31 Some differentially expressed lncRNAs play important roles in osteogenic differentiation and bone regeneration. 32, 33 In addition, differentially expressed circRNAs including circRNA_007438 and circRNA_005108, 34 circRNA BANP, and circRNA ITCH play modulatory roles during osteoclastogenesis and osteogenic differentiation. 35 However, the differential expression profiles of circRNA in PMOP BMSCs exosomes have not been explored and their regulatory mechanism on osteogenic, and adipogenic differentiation of BMSCs is not fully known.

In the current study, BMSCs-derived exosomes were obtained from PMOP patients and control groups, and circRNA expression F I G U R E 5 The circRNA-miRNA-mRNA network. Blue diamonds represent circRNAs. Red rectangles represent miRNAs. Yellow ovals represent mRNAs Osteoclast-derived exosomal miR-214 enhances osteoclastogenesis by modulating PI3K/Akt signaling by targeting phosphatase and tensin homolog. 36 Analysis showed that Hsa_circ_0058392 interacts with hsa-miR-221, which negatively regulates osteogenic differentiation by repressing RUNX2, and were downregulated in exosomes from BMSCs. 37 Hsa-miR-148a-3p, hsa-miR-338-3p, hsa-miR-124-3p, hsa-miR-155, hsa-miR-221, and hsa-miR-214 were recently reported to play important roles in osteogenesis 38, 39 ; therefore, the findings of the current study provide information on the regulatory mechanism.

The findings show the role of hsa_circ_0009127, hsa_circ_0090759, hsa_circ_0058392, hsa_circ_0090247, and hsa_circ_0049484.

However, circRNA-related ceRNA networks in PMOP are complex.

The finding of the present study provided a basis for further explor- 40 KEGG pathway analysis showed that these differentially expressed circRNAs may be implicated in the regulation of autophagy, PI3K-Akt signaling, FoxO signaling, and MAPK signaling. Previous studies report that autophagy regulates osteoblast differentiation. 41, 42 Additionally, autophagy counteracts oxidative stress elevation during aging; thus, autophagy plays an important roles in PMOP. 43 PI3K-Akt signaling promotes osteoblast proliferation, differentiation, and osteogenesis, thus inhibiting osteoporosis. 44 Osteogenic differentiation of BMSCs into osteoblasts is a well-controlled process modulated by several factors such as Runx2, β-catenin, Osx, and alkaline phosphatase. 45 Recent studies report that interactions between FoxO members and differentiation modulatory factors lead to bidirectional modulation of osteogenic differentiation in MSCs. 46 MAPK signal pathway is the core regulatory pathway triggered by hypoxia, and hypoxia affects the cell cycle, proliferation, apoptosis, migration, and differentiation of MSCs. 47, 48 Although PMOP regulation by genes identified in the current study was not explored, the study of exosomes from PMOP patients' BMSCs provides a basis for the understanding of PMOP pathogenesis.

In the current study, the expression of circRNAs in PMOP patients' BMSCs exosomes and normal control BMSCs exosomes was explored. A total of 5 differentially expressed circRNAs (hsa_circ_0009127, hsa_circ_0090759, hsa_circ_0058392, hsa_ circ_0090247, and hsa_circ_0049484), which can be used as potential PMOP biomarkers and potential therapeutic targets for the treatment of PMOP were identified. A total of 516 differentially expressed circRNAs were identified. Most of these circRNAs are implicated in pathological processes linked to the regulation of autophagy, PI3K-Akt signaling, FoxO signaling, and MAPK signaling. Although the study was limited to functional analysis and did not perform functional verification, these findings provide information on the role of circRNAs in the etiology and pathogenesis of PMOP. 

Clinical practice. Postmenopausal osteoporosis

Osteoporotic fractures in postmenopausal women

Potential diagnostic value of PD-1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients

Systemic immuneinflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture

Exploring the application of mesenchymal stem cells in bone repair and regeneration

Stem cell therapy for osteoporosis

MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus

Osteoclast-derived extracellular vesicles: novel regulators of osteoclastogenesis and osteoclastosteoblasts communication in bone remodeling

Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy

MSC exosome as a cell-free MSC therapy for cartilage regeneration: implications for osteoarthritis treatment

Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression

Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion

Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis

Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A

Exosomes secreted by humaninduced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats

Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration

Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis

Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets

The biogenesis, functions, and challenges of circular RNAs

Circles reshaping the RNA world: from waste to treasure

CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene

FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition

Transcriptome analysis by strand-specific sequencing of complementary DNA

An exploratory study of articular cartilage and subchondral bone reconstruction with bone marrow mesenchymal stem cells combined with porous tantalum/Bio-Gide collagen membrane in osteonecrosis of the femoral head

Parathyroid hormone directs bone marrow mesenchymal cell fate

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm

Mesenchymal stem cell exosomes

Mesenchymal stromal/ stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro

Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction

Systematic analysis of lncRNAs, mRNAs, circRNAs and miRNAs in patients with postmenopausal osteoporosis

Long non-coding RNA-DANCR in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis

LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR133a-3p

Lnc-NTF3-5 promotes osteogenic differentiation of maxillary sinus membrane stem cells via sponging miR-93-3p

Changing expression profiles of ln-cRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis

Identification and integrated analysis of differentially expressed lncRNAs and circRNAs reveal the potential ceRNA networks during PDLSC osteogenic differentiation

miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway

Altered microRNA expression profile in exosomes during osteogenic differentiation of human bone marrow-derived mesenchymal stem cells

The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling

Stem cell derived exosomes: microRNA therapy for age-related musculoskeletal disorders

Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers

Hedgehog signaling regulates osteoblast differentiation in zebrafish larvae through modulation of autophagy

Autophagy in osteoblasts is involved in mineralization and bone homeostasis

Reactive oxygen species and exercise on bone metabolism: friend or enemy?

The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis

Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblastmediated bone formation

Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs

Altered expression of circular RNAs in human placental chorionic plate-derived mesenchymal stem cells pretreated with hypoxia

Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells